MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CYCN Cyclerion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

CYCN is expected to report earnings to rise 75.00% to -28 cents per share on August 08

Cyclerion Therapeutics CYCN Stock Earnings Reports
Q2'23
Est.
$-0.28
Q1'23
Beat
by $0.14
Q4'22
Beat
by $0.12
Q3'22
Beat
by $5.96
Q2'22
Missed
by $0.01
The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 10.10K shares outstanding, the current market capitalization sits at 6.58M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CYCN and Stocks

Correlation & Price change

A.I.dvisor tells us that CYCN and FRES have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCN and FRES's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-1.88%
FRES - CYCN
31%
Poorly correlated
-2.01%
KZIA - CYCN
26%
Poorly correlated
-10.61%
ENTO - CYCN
25%
Poorly correlated
+2.41%
CGEN - CYCN
23%
Poorly correlated
-8.57%
OCEA - CYCN
21%
Poorly correlated
-7.96%
More